Skip to main content
. 2021 Dec 7;2021(12):CD004044. doi: 10.1002/14651858.CD004044.pub5

Comparison 6. Antidepressant plus antipsychotic versus placebo plus antipsychotic.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
6.1 Clinical response 4 447 Risk Ratio (M‐H, Fixed, 95% CI) 1.83 [1.40, 2.38]
6.1.1 Amitriptyline + perphenazine vs perphenazine 1 39 Risk Ratio (M‐H, Fixed, 95% CI) 3.61 [1.23, 10.56]
6.1.2 Fluoxetine + olanzapine vs olanzapine 2 149 Risk Ratio (M‐H, Fixed, 95% CI) 1.64 [1.10, 2.44]
6.1.3 Olanzapine + sertraline vs olanzapine 1 259 Risk Ratio (M‐H, Fixed, 95% CI) 1.76 [1.21, 2.54]
6.2 Dropouts 4 447 Risk Ratio (M‐H, Fixed, 95% CI) 0.79 [0.63, 1.01]
6.2.1 Amitriptyline + perphenazine vs perphenazine 1 39 Risk Ratio (M‐H, Fixed, 95% CI) 3.09 [0.38, 25.19]
6.2.2 Fluoxetine + olanzapine vs olanzapine 2 149 Risk Ratio (M‐H, Fixed, 95% CI) 0.95 [0.59, 1.53]
6.2.3 Olanzapine + sertraline vs olanzapine 1 259 Risk Ratio (M‐H, Fixed, 95% CI) 0.70 [0.53, 0.92]